Enbiosis Biotechnology Limited
13111010
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
Persons with Significant Control
Mr Omer Ozkan
Turkish · England · Age 41
Flat 603, Patterson Tower, 301 Kidbrooke Park Road, London, SE3 9FY
Notified 04/01/2021
CompanyRankvs 377+ SIC 72110 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£1.0M
Balance sheet strength
Cash
£3k
Cash in the bank
Net Current Assets
£535k
Working capital
Current Assets
£949k
Current Liabilities
£413k
Fixed Assets
£477k
Debtors
£946k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.29 | +£229k |
| 2023 | 1.54 | -£85k |
| 2022 | 205.56 | +£397k |
| 2021 | 1756.69 | — |
Derived from filed accounts. Not audited figures.